RESCAP® IN SEVERE BURN WOUND TRIAL

Alloksys’s RESCAP® platform therapeutic compound will be applied in patients that suffer from severe burn trauma. RESCAP® administration is expected to significantly attenuate the overall ischemic clinical condition of these severely burn-patients and thereby improve on recuperation of these patients, primarily during ICU treatment period. The study will be carried out at the Burn Centre, […]